Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 27, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Waters Introduces the Xevo TQ-S micro Tandem Quadrupole Mass Spectrometer
Monday, June 16, 2014
New Mass Spectrometer Packs Impressive Performance into a Compact Design. The dependable choice for quantitative UPLC/MS/MS analyses.

Waters’ New Xevo G2-XS QTof Mass Spectrometer, Bringing Uncompromised Sensitivity and Exceptional Quantitative Ability to MS
Monday, June 16, 2014
New Collision Cell Technology Gives Laboratories Powerful New Quadrupole Time-of-Flight MS System for Targeted Quantification and Qualitative Analyses.

New Brochure from Malvern Instruments
Saturday, June 14, 2014
New brochure guides Gel Permeation/Size Exclusion Chromatography detectors choice.

Phenomenex Announces the Extension of its Lux Chiral Bulk Media Line
Tuesday, June 10, 2014
Company adds Lux Cellulose-3 and Cellulose-4 phases to chiral bulk media line for preparative chromatography.

Revolutionary Ion-source Technology Receives Official Recognition
Tuesday, June 03, 2014
Markes Select-eV has received an Honourable Mention at the Pittcon Editors’ Awards.

Sensitive and Robust Assay for Ammonia in Sodium Bicarbonate
Friday, May 30, 2014
Analysis of ammonia in sodium bicarbonate by using new ion chromatography based method.

Efficiently Determine Growth Stimulants in Meat
Saturday, May 24, 2014
Determination of clenbuterol, ractopamine, and phenolethanolamine by using a dual rapid separation LC system.

Shimadzu Introduces C2P Automated Purification/Powderization System
Thursday, May 15, 2014
Crude2Pure for improved purity, efficiency and productivity.

Markes Announces Productivity-enhancing Improvements to its Range of TD Instruments
Thursday, May 15, 2014
Company has also announced improvements to its SafeLok TD sampling tubes.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 758
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv